2013
DOI: 10.1016/j.bbalip.2013.02.001
|View full text |Cite
|
Sign up to set email alerts
|

New insights on the role of ceramide 1-phosphate in inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
39
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 54 publications
(42 citation statements)
references
References 110 publications
2
39
0
1
Order By: Relevance
“…Such treatments are considered to affect the lateral diffusion, aggregation, and function of receptor complexes (37). Bioactive lipids, such as ceramides and sphingosine 1-phosphate, are known to regulate inflammation in cells and to activate several signaling pathways (38). Therefore, it is reasonable to infer that HP-b-CD activates the innate immune response and exerts its adjuvant activity by modifying these lipid-dependent biological processes.…”
Section: Discussionmentioning
confidence: 99%
“…Such treatments are considered to affect the lateral diffusion, aggregation, and function of receptor complexes (37). Bioactive lipids, such as ceramides and sphingosine 1-phosphate, are known to regulate inflammation in cells and to activate several signaling pathways (38). Therefore, it is reasonable to infer that HP-b-CD activates the innate immune response and exerts its adjuvant activity by modifying these lipid-dependent biological processes.…”
Section: Discussionmentioning
confidence: 99%
“…It is remarkable that while the role of S1P and S1P receptor-agonists/antagonists in the pathogenesis of inflammatory disorders has been extensively studied in vivo using translational mouse models of human diseases [9,10,25], the knowledge concerning the function of exogenous C1P in modulating immune responses is, at present, mostly limited to in vitro observations [26,27]. Both pro-and anti-inflammatory behaviour of exogenous C1P has been described.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, our observation that C1P inhibits CS-induced IL-8 production in AECs and neutrophils further strengthens our assumption that C1P might be a new therapeutic target for COPD. The potential of C1P to dampen pro-inflammatory cytokine production has also been reported for LPS-induced TNF-α, MIP-2, IL-6 and IL-8 in human embryonic kidney cells, human blood mononuclear cells, endothelial cells and mastocytes [27,33,37].…”
Section: Figurementioning
confidence: 99%
“…A predominant metabolite of ceramide is ceramide-1-phosphate (C1P), which can be formed via the phosphorylation of ceramide by ceramide kinase (25,26). The C1P receptor is coupled to inhibitory guanine nucleotide-binding regulatory (Gi) proteins and causes the activation of the PI3K/Akt signaling pathway to facilitate cell survival (25,27,28).…”
Section: Discussionmentioning
confidence: 99%